BridgeBio Pharma, Inc. (BBIO) stock
BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$76.80−0.56 (-0.72%)
Close on Nov 17, 2026Market cap $14.96BP/E –Yield –
BridgeBio Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BridgeBio Pharma's market cap was $15.53B on Nov 11, 2026, against $13.87B a year earlier. Over the last 5 years it ranged from $1.01B to $15.67B, with a median of $5.24B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $15.53B | +5.4% |
| 2025 | Dec 31, 2025 | $14.73B | +184.1% |
| 2024 | Dec 31, 2024 | $5.19B | -26.2% |
| 2023 | Dec 29, 2023 | $7.03B | +517.6% |
| 2022 | Dec 30, 2022 | $1.14B | -53.6% |
| 2021 | Dec 31, 2021 | $2.45B | -71.8% |
| 2020 | Dec 31, 2020 | $8.71B | +111.8% |
| 2019 | Dec 31, 2019 | $4.11B | – |
See a number that looks wrong?